Blue Owl Technology Finance Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 30, 2026.
Edgewise Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 4, 2026, disclosing operational and financial information for the third quarter of fiscal year 2026.
ARKO Petroleum Corp. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 30, 2026.
Viper Energy, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing share counts, capital structure details, and financial results for the third quarter of 2026.
Xencor, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, disclosing a consolidated balance sheet reflecting a decline in total assets from $875.5 million at year-end 2025 to $770.5 million.
Winchester Bancorp, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the three months ended September 30, 2026, reporting net income of $1.268 million on total assets of $1.141 billion.
Todd Watanabe, President and Chief Executive Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), filed a Form 4 on November 4, 2026, disclosing the sale of 4,377 shares of common stock on November 2, 2026, to cover tax withholding obligations related to the vesting of Restricted …
An amended initial statement of beneficial ownership was filed on November 4, 2026, disclosing director Robert A. Scott's holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) as of the event date of October 23, 2026.
Patrick Burnett, EVP and Chief Medical Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), filed a Form 4 on November 4, 2026, disclosing the sale of 943 shares of common stock on November 2, 2026, to cover tax withholding obligations arising from the vesting of Restricted …
Christopher M. Hall, Chief Executive Officer and Director of Personalis, Inc., filed a statement of changes in beneficial ownership on November 4, 2026, disclosing a sale of 29,112 shares of common stock on November 3, 2026.